Preclinical rodent models of cardiac fibrosis-Reference-Cited by-同舟云学术

Preclinical rodent models of cardiac fibrosis

Published:2021-05-10 Issue: Volume: Page:
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Wang Yan¹^ORCID,Wang Miao²,Samuel Chrishan S.¹^ORCID,Widdop Robert E.¹

Affiliation:

1. Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Pharmacology Monash University Clayton Victoria Australia

2. State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15450

Reference156 articles.

1. Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

3. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors

4. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

5. Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence;European Journal of Pharmacology;2024-07

2. The isoproterenol-induced myocardial fibrosis: A biochemical and histological investigation;Biomedicine & Pharmacotherapy;2024-05

3. JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target;Frontiers in Pharmacology;2024-03-01

4. Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management;Hypertension;2024-02

5. The Application of Berberine in Fibrosis and the Related Diseases;The American Journal of Chinese Medicine;2024-01